Abeona Therapeutics Inc.

NASDAQ:ABEO

Biotechnology

Healthcare
$2.60 +1.06%

+$0.06 today

Market cap
$148.58M
Beta
1.35
P/E (TTM)
4.9
EPS (TTM)
$1.17
52W Low $4.00High $7.54

Volume 1.71M

Average 1.12M

Returns on capital

Abeona Therapeutics Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

44.7%

avg -94.6%

ROIC

-44.0%

avg -58.1%

ROA

32.4%

avg -41.3%

Analysis

ROE is currently the strongest return metric at 44.7% versus its period average of -94.6%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Vishwas Seshadri

President, Chief Executive Officer & DirectorUSD 1.52M501.29M2.26%

Joseph Walter Vazzano

Chief Financial OfficerUSD 898.47K42482.89K0.85%

Brendan O'Malley

Chief Legal OfficerUSD 783.93K57——

Madhav Vasanthavada

Senior Vice President, Chief Commercial Officer & Head of Business Development—47285.72K0.50%

Brian Kevany

Chief Technical & Scientific Officer————

Carl Denny

Senior Vice President of Regulatory Affairs————

Gianine Esposito

Senior VP & Chief People Officer————

Gregory Gin

Vice President of Investor Relations & Corporation Communications————

Jon Voss

Vice President & Head of Quality—66——

Megan Callan

Vice President & Head of Quality————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 29, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

37

$3.50M

Net Transaction Value

−$3.50M

Net selling

Most Active

Vazzano Joseph Walter

8 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 29, 26

Seshadri Vishwas

Direct

Sell$101.1K
Sep 29, 26

Vasanthavada Madhav

Direct

Sell$25.3K
Sep 29, 26

Vazzano Joseph Walter

Direct

Sell$47.4K
Sep 29, 26

O'Malley Brendan M.

Direct

Sell$34.7K
Sep 1, 26

Alvino Mark

Direct

Sell$88K
Jul 21, 26

Vazzano Joseph Walter

Direct

Sell$9.7K
Jul 9, 26

Vasanthavada Madhav

Direct

Sell$87.8K
Jul 9, 26

Vazzano Joseph Walter

Direct

Sell$173.3K
Jul 9, 26

Seshadri Vishwas

Direct

Sell$473.3K
Jul 9, 26

O'Malley Brendan M.

Direct

Sell$83.9K

1–10 of 37

Summary

Insiders reported 0 buys worth $0.00 and 37 sells worth $3.50M over the last 12 months. That adds up to net selling of $3.50M. Vazzano Joseph Walter was the most active insider with 8 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
+11.6% (5yr)1 analysts
RevenueN/AN/A+60.3%
+124.0% (5yr)2 analysts
Net IncomeN/AN/AN/A
+10.2% (5yr)2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +60.3% over three years. Forward estimates point to Revenue at +124.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Abeona Therapeutics Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ABEO's management, answered from reported figures.

Who manages ABEO?

Abeona Therapeutics Inc. (ABEO) lists 10 active executives. The top listed executive is Brendan O'Malley, Chief Legal Officer.

Are ABEO insiders buying or selling?

Recent insider activity shows net selling of $4.32M.